Neue Suche | Kongressdetail
mail
Druckansicht
 
 

Neurodevelopmental Drug Development Summit

Evvnt Promotion / evvnt
-
14.12.2021 - 15.12.2021  Online
Time: 8:30 am - 6:15 pm
 
Kongressthemen
As investment in rare neurodevelopmental disorders is surging, there has never been a better time to unite all the key stakeholders across this fast-evolving community.

The inaugural Neurodevelopmental Drug Development Summit is the definitive industry-dedicated forum for large pharma, biotech, academia, and patient advocacy groups paving the way towards symptomatic and successful disease modifying treatments.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/867375-3?pid=4832

Speakers: Allyson Berent Chief Operating Officer | FAST GeneTx | Biotherapeutics Chief Scientific Officer, Anish Bhatnagar Chief Executive Officer Soleno Therapeutics and more
 

Anfragen und Anmeldung:

https://go.evvnt.com/867375-2?pid=4832
Frau Stephanie Nketia
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
Conference Only - Drug Developer: USD 2099.00, Conference Only - Academic: USD 1899.00, Conference Only - Service Provider: USD 2599.00
Teilnehmer erwartet
1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Helix - Forschung & Beratung WienEuropean Public Health Association (EUPHA)Österreichische Gesellschaft für Public HealthEuropean Health Forum GasteinSwiss Tropical and Public Health InstituteÖsterreichisches Rotes KreuzAlumni Club Medizinische Universität WienAMREF - African Medical and Research Foundation